Literature DB >> 9207070

Posttranscriptional modification of retroviral primers is required for late stages of DNA replication.

B P Burnett1, C S McHenry.   

Abstract

During reverse transcription of retroviral RNA, synthesis of (-) strand DNA is primed by a cellular tRNA that anneals to an 18-nt primer binding site within the 5' long terminal repeat. For (+) strand synthesis using a (-) strand DNA template linked to the tRNA primer, only the first 18 nt of tRNA are replicated to regenerate the primer binding site, creating the (+) strand strong stop DNA intermediate and providing a 3' terminus capable of strand transfer and further elongation. On model HIV templates that approximate the (-) strand linked to natural modified or synthetic unmodified tRNA3Lys, we find that a (+) strand strong stop intermediate of the proper length is generated only on templates containing the natural, modified tRNA3Lys, suggesting that a posttranscriptional modification provides the termination signal. In the presence of a recipient template, synthesis after strand transfer occurs only from intermediates generated from templates containing modified tRNA3Lys. Reverse transcriptase from Moloney murine leukemia virus and avian myoblastosis virus shows the same requirement for a modified tRNA3Lys template. Because all retroviral tRNA primers contain the same 1-methyl-A58 modification, our results suggest that 1-methyl-A58 is generally required for termination of replication 18 nt into the tRNA sequence, generating the (+) strand intermediate, strand transfer, and subsequent synthesis of the entire (+) strand. The possibility that the host methyl transferase responsible for methylating A58 may provide a target for HIV chemotherapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207070      PMCID: PMC23794          DOI: 10.1073/pnas.94.14.7210

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Site on the RNA of an avian sarcoma virus at which primer is bound.

Authors:  J M Taylor; R Illmensee
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

2.  A primer ribonucleic acid for initiation of in vitro Rous sarcarcoma virus deoxyribonucleic acid synthesis.

Authors:  F Harada; R C Sawyer; J E Dahlberg
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

3.  Nucleotide sequence that binds primer for DNA synthesis to the avian sarcoma virus genome.

Authors:  B Cordell; E Stavnezer; R Friedrich; J M Bishop; H M Goodman
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

4.  Molecular analysis of the second template switch during reverse transcription of the HIV RNA template.

Authors:  H Ben-Artzi; J Shemesh; E Zeelon; B Amit; L Kleiman; M Gorecki; A Panet
Journal:  Biochemistry       Date:  1996-08-13       Impact factor: 3.162

5.  RNA-directed DNA polymerase of Rous sarcoma virus: initiation of synthesis with 70 S viral RNA as template.

Authors:  A J Faras; J M Taylor; W E Levinson; H M Goodman; J M Bishop
Journal:  J Mol Biol       Date:  1973-09-05       Impact factor: 5.469

6.  Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer).

Authors:  C Isel; C Ehresmann; G Keith; B Ehresmann; R Marquet
Journal:  J Mol Biol       Date:  1995-03-24       Impact factor: 5.469

7.  Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3Lys) and DNA-tRNA(3Lys) hybrids.

Authors:  G Yusupova; J M Lanchy; M Yusupov; G Keith; S F Le Grice; C Ehresmann; B Ehresmann; R Marquet
Journal:  J Mol Biol       Date:  1996-08-23       Impact factor: 5.469

8.  Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase.

Authors:  H E Huber; C C Richardson
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.

Authors:  J H Condra; W A Schleif; O M Blahy; L J Gabryelski; D J Graham; J C Quintero; A Rhodes; H L Robbins; E Roth; M Shivaprakash
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

10.  Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys.

Authors:  C Isel; J M Lanchy; S F Le Grice; C Ehresmann; B Ehresmann; R Marquet
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

View more
  13 in total

1.  In vitro evidence for the interaction of tRNA(3)(Lys) with U3 during the first strand transfer of HIV-1 reverse transcription.

Authors:  F Brulé; G Bec; G Keith; S F Le Grice; B P Roques; B Ehresmann; C Ehresmann; R Marquet
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Genome-wide analysis of N1-methyl-adenosine modification in human tRNAs.

Authors:  Mridusmita Saikia; Ye Fu; Mariana Pavon-Eternod; Chuan He; Tao Pan
Journal:  RNA       Date:  2010-05-19       Impact factor: 4.942

3.  In vivo Ty1 reverse transcription can generate replication intermediates with untidy ends.

Authors:  E H Mules; O Uzun; A Gabriel
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  The bipartite structure of the tRNA m1A58 methyltransferase from S. cerevisiae is conserved in humans.

Authors:  Sarah Ozanick; Annette Krecic; Joshua Andersland; James T Anderson
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

5.  Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1.

Authors:  M J Renda; J D Rosenblatt; E Klimatcheva; L M Demeter; R A Bambara; V Planelles
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems.

Authors:  T Wu; J Guo; J Bess; L E Henderson; J G Levin
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  NMR and biochemical characterization of recombinant human tRNA(Lys)3 expressed in Escherichia coli: identification of posttranscriptional nucleotide modifications required for efficient initiation of HIV-1 reverse transcription.

Authors:  C Tisné; M Rigourd; R Marquet; C Ehresmann; F Dardel
Journal:  RNA       Date:  2000-10       Impact factor: 4.942

8.  Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAs.

Authors:  Takeshi Chujo; Tsutomu Suzuki
Journal:  RNA       Date:  2012-10-24       Impact factor: 4.942

9.  High-throughput sequencing of human plasma RNA by using thermostable group II intron reverse transcriptases.

Authors:  Yidan Qin; Jun Yao; Douglas C Wu; Ryan M Nottingham; Sabine Mohr; Scott Hunicke-Smith; Alan M Lambowitz
Journal:  RNA       Date:  2015-11-09       Impact factor: 4.942

10.  Crystal structure of tRNA m(1)A58 methyltransferase TrmI from Aquifex aeolicus in complex with S-adenosyl-L-methionine.

Authors:  Mitsuo Kuratani; Tatsuo Yanagisawa; Ryohei Ishii; Michiyo Matsuno; Shu-Yi Si; Kazushige Katsura; Ryoko Ushikoshi-Nakayama; Rie Shibata; Mikako Shirouzu; Yoshitaka Bessho; Shigeyuki Yokoyama
Journal:  J Struct Funct Genomics       Date:  2014-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.